SCHEMBL8355407

SCHEMBL8355407

CCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(Cc2ccccc2)c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 3/20 1.00
ADORA1 P30542 6/20 0.77
ADORA2A P29274 4/20 0.77
ADORA2B P29275 3/20 0.77
MEN1 O00255 1/20 0.77
GMNN O75496 1/20 0.77
LMNA P02545 1/20 0.77
CYP1A2 P05177 1/20 0.77
TSHR P16473 1/20 0.77
PMP22 Q01453 1/20 0.77
KMT2A Q03164 1/20 0.77
HIF1A Q16665 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8358871 0.97 ADORA3 (0.94) ADORA3ADORA1ADORA2AADORA2BMEN1
SCHEMBL8580754 0.92 ADORA3 (0.85) ADORA3ADORA1ADORA2AADORA2BMEN1
SCHEMBL8577955 0.90 ADORA3 (0.81) ADORA3ADORA1ADORA2AADORA2BMEN1
1,3-Dipropyl-8-Cyclopentylxanthine [Dpcpx] SCHEMBL382422 0.88 ADORA1 (1.00) ADORA3ADORA1ADORA2AADORA2BMEN1
SCHEMBL4623484 0.87 ADORA1 (1.00) ADORA3ADORA1ADORA2AADORA2BMEN1
SCHEMBL4621677 0.83 ADORA1 (1.00) ADORA3ADORA1ADORA2AADORA2BMEN1
SCHEMBL8575307 0.82 ADORA2A (0.80) ADORA3ADORA1ADORA2AADORA2BMEN1
SCHEMBL8578131 0.82 ADORA1 (0.88) ADORA3ADORA1ADORA2AADORA2BMEN1
SCHEMBL8576778 0.82 ADORA1 (0.88) ADORA3ADORA1ADORA2AADORA2BMEN1
SCHEMBL8579145 0.82 ADORA1 (0.71) ADORA3ADORA1ADORA2AADORA2BMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999031101-A1 ADENOSINE RECEPTOR ANTAGONISTS WITH IMPROVED BIOACTIVITY UNIVERSITY OF SOUTH FLORIDA (US) 1999-06-24 WO disclosed